Aptinyx Inc | APTX - Ebit

Aptinyx Inc reported $-14657000 in EBIT for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Ebit Change
Acadia Pharmaceuticals ACAD:US USD -46063000 15.2M
Acorda Therapeutics ACOR:US USD 269K 5.26M
Biogen BIIB:US USD 878.7M 6.6M
Cara Therapeutics CARA:US USD -31307000 7.46M
Daiichi Sankyo 4568:JP JPY 31.55B 29.65B
Eli Lilly And LLY:US USD 2.11B 169.2M
Halozyme Therapeutics HALO:US USD 75.91M 7.78M
Intra Cellular Therapies ITCI:US USD -47412000 8.22M
IONIS PHARMACEUT IONS:US USD -208019000 148.86M
Marinus Pharmaceuticals MRNS:US USD -29212000 887K
Neurocrine Biosciences NBIX:US USD 103.4M 15.6M
Novartis NOVN:VX USD 3.1B 228M
Ultragenyx Pharmaceutical RARE:US USD -145628000 79.44M
Vertex Pharmaceuticals VRTX:US USD 1.04B 89.7M